Commentary: Initial experience in treating polypoidal choroidal vasculopathy with brolucizumab in Indian eyes - A multicenter retrospective study.
作者信息
Gopal Lingam
机构信息
National University Health System, Singapore; National University of, Singapore.
出版信息
Indian J Ophthalmol. 2022 Apr;70(4):1301. doi: 10.4103/ijo.IJO_648_22.
Abstract
摘要
相似文献
1
Commentary: Initial experience in treating polypoidal choroidal vasculopathy with brolucizumab in Indian eyes - A multicenter retrospective study.评论：在印度患者眼中使用布罗珠单抗治疗息肉状脉络膜血管病变的初步经验——一项多中心回顾性研究。
Indian J Ophthalmol. 2022 Apr;70(4):1301. doi: 10.4103/ijo.IJO_648_22.
2
Initial experience in treating polypoidal choroidal vasculopathy with brolucizumab in Indian eyes - A multicenter retrospective study.在印度眼内使用 brolucizumab 治疗息肉样脉络膜血管病变的初步经验——一项多中心回顾性研究。
Indian J Ophthalmol. 2022 Apr;70(4):1295-1299. doi: 10.4103/ijo.IJO_2513_21.
3
Short-term results for brolucizumab in treatment-naïve neovascular age-related macular degeneration: a Japanese multicenter study.治疗初发新生血管性年龄相关性黄斑变性的 brolucizumab 短期疗效：一项日本多中心研究。
Jpn J Ophthalmol. 2022 Jul;66(4):379-385. doi: 10.1007/s10384-022-00922-3. Epub 2022 May 21.
4
Subfoveal choroidal thickness after brolucizumab therapy for neovascular age-related macular degeneration: a short-term multicenter study.经 brolucizumab 治疗新生血管性年龄相关性黄斑变性后的黄斑中心凹下脉络膜厚度：一项短期多中心研究。
Graefes Arch Clin Exp Ophthalmol. 2022 Jun;260(6):1857-1865. doi: 10.1007/s00417-021-05517-1. Epub 2022 Jan 16.
5
One-year outcomes of intravitreal bevacizumab (avastin) therapy for polypoidal choroidal vasculopathy.眼内注射bevacizumab（阿瓦斯汀）治疗息肉样脉络膜血管病变的一年疗效观察。
Retina. 2011 May;31(5):846-56. doi: 10.1097/IAE.0b013e3181f84fdf.
6
Brolucizumab in polypoidal choroidal vasculopathy.布罗鲁单抗治疗息肉样脉络膜血管病变
Expert Opin Biol Ther. 2022 Jul;22(7):809-812. doi: 10.1080/14712598.2022.2094239. Epub 2022 Jun 27.
7
En-face high-penetration optical coherence tomography imaging in polypoidal choroidal vasculopathy.息肉样脉络膜血管病变的表面高穿透光学相干断层扫描成像
Br J Ophthalmol. 2015 Jan;99(1):29-35. doi: 10.1136/bjophthalmol-2013-304658. Epub 2014 Aug 8.
8
Correlation of indocyanine green angiography and optical coherence tomography findings after intravitreal ranibizumab for polypoidal choroidal vasculopathy.吲哚菁绿血管造影与玻璃体内雷珠单抗治疗息肉状脉络膜血管病变后光学相干断层扫描结果的相关性。
Retina. 2012 Nov-Dec;32(10):2006-13. doi: 10.1097/IAE.0b013e31825c1c31.
9
Immediate onset of sterile endophthalmitis with hypopyon after intravitreal Brolucizumab in a case of polypoidal choroidal vasculopathy.在一例息肉样脉络膜血管病变患者中，玻璃体内注射布罗珠单抗后立即发生伴有前房积脓的无菌性眼内炎。
Indian J Ophthalmol. 2021 Feb;69(2):469-470. doi: 10.4103/ijo.IJO_3436_20.
10
Anti-vascular endothelial growth factor monotherapy in the treatment of submacular hemorrhage secondary to polypoidal choroidal vasculopathy.抗血管内皮生长因子单药治疗继发于息肉样脉络膜血管病变的黄斑下出血。
Am J Ophthalmol. 2013 Sep;156(3):524-531.e1. doi: 10.1016/j.ajo.2013.04.029. Epub 2013 Jun 13.
本文引用的文献
1
Initial experience in treating polypoidal choroidal vasculopathy with brolucizumab in Indian eyes - A multicenter retrospective study.在印度眼内使用 brolucizumab 治疗息肉样脉络膜血管病变的初步经验——一项多中心回顾性研究。
Indian J Ophthalmol. 2022 Apr;70(4):1295-1299. doi: 10.4103/ijo.IJO_2513_21.
Zotero 插件